Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study

Autor: Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Echegoyen J, Kannarr SR, Rodriguez TC, Dickerson JE Jr

Publikováno v: Clinical Ophthalmology, Vol Volume 18, Pp 1525-1534 (2024)

Brandon D Ayres,1 Marc R Bloomenstein,2 Jennifer Loh,3 Thomas Chester,4 Bobby Saenz,5,6 Julio Echegoyen,7 Shane R Kannarr,8 Tomasita C Rodriguez,9 Jaime E Dickerson Jr9,10 1Private Practice, Philadelphia, PA, USA; 2Schwartz Laser Eye Center, Scottsda

Externí odkaz: https://doaj.org/article/86b88c29c64049c089e0988d51d39ad2

A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter]

Autor: Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Echegoyen J, Kannarr SR, Perez VL, Rodriguez TC, Dickerson Jr JE

Publikováno v: Clinical Ophthalmology, Vol Volume 18, Pp 885-886 (2024)

Brandon D Ayres,1 Marc R Bloomenstein,2 Jennifer Loh,3 Thomas Chester,4 Bobby Saenz,5,6 Julio Ehegoyen,7 Shane R Kannarr,8 Victor L Perez,9 Tomasita C Rodriguez,10 Jaime E Dickerson Jr10,11 1Private Practice, Philadelphia, PA, USA; 2Schwartz Laser Ey

Externí odkaz: https://doaj.org/article/b28698b4cd7e4172b325f1e6a2f9fe9c

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Autor: Bacharach J, Wirta DL, Smyth-Medina R, Korenfeld MS, Kannarr SR, Foster S, Jaros MJ, Slonim CB

Publikováno v: Clinical Ophthalmology, Vol Volume 15, Pp 2743-2751 (2021)

Jason Bacharach,1 David L Wirta,2 Robert Smyth-Medina,3 Michael S Korenfeld,4 Shane R Kannarr,5 Shane Foster,6 Mark J Jaros,7 Charles B Slonim8 1North Bay Eye Associates, Petaluma, CA, USA; 2Aesthetic Eye Care Institute & Eye Research Foundation, New

Externí odkaz: https://doaj.org/article/bf630f6b36144f9b8a9db37d4c1f1f1b

Improved Signs and Symptoms of Dry Eye Disease for Restasis ^® Patients Following a Single Tearcare ^® Treatment: Phase 2 of the SAHARA Study.

Autor: Ayres BD; Private Practice, Philadelphia, PA, USA., Bloomenstein MR; Schwartz Laser Eye Center, Scottsdale, AZ, USA., Loh J; Loh Ophthalmology Associates, Miami, FL, USA., Chester T; Cleveland Eye Clinic, Brecksville, OH, USA., Saenz B; Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.; LASIK San Antonio, Kerrville, TX, USA., Echegoyen J; Gordon Schanzlin New Vision Institute, La Jolla, CA, USA., Kannarr SR; Kannarr Eye Care, Pittsburg, KS, USA., Rodriguez TC; Sight Sciences, Menlo Park, CA, USA., Dickerson JE Jr; Sight Sciences, Menlo Park, CA, USA.; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 May 28; Vol. 18, pp. 1525-1534. Date of Electronic Publication: 2024 May 28 (Print Publication: 2024).

A Randomized, Controlled Trial Comparing Tearcare ^® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA).

Autor: Ayres BD; Private Practice, Philadelphia, PA, USA., Bloomenstein MR; Schwartz Laser Eye Center, Scottsdale, AZ, USA., Loh J; Loh Ophthalmology Associates, Miami, FL, USA., Chester T; Cleveland Eye Clinic, Brecksville, OH, USA., Saenz B; Rosenberg School of Optometry, University of the Incarnate Word, San Antonio, TX, USA.; LASIK San Antonio, Kerrville, TX, USA., Echegoyen J; Gordon Schanzlin New Vision Institute, La Jolla, CA, USA., Kannarr SR; Kannarr Eye Care, Pittsburg, KS, USA., Perez VL; Department of Ophthalmology, Duke University Medical Center, Durham, NC, USA., Rodriguez TC; Sight Sciences, Menlo Park, CA, USA., Dickerson JE Jr; Sight Sciences, Menlo Park, CA, USA.; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2023 Dec 18; Vol. 17, pp. 3925-3940. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023).